InSight
Diagnostic TestClinical decision support (CDS) system for severe sepsis detection and prediction
NCT Number: NCT03960203
In this clinical outcomes analysis, the effect of a machine learning algorithm for severe sepsis prediction on in-hospital mortality, hospital length of stay, and 30-day readmission was evaluated.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Materials and Methods: Clinical outcomes evaluation performed on a multiyear, multicenter clinical data set of real-world data containing 75,147 patient encounters from nine hospitals. Mortality, hospital length of stay, and 30-day readmission analysis performed for 17,758 adult patients who met two or more Systemic Inflammatory Response Syndrome (SIRS) criteria at any point during their stay.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clinical decision support (CDS) system for severe sepsis detection and prediction
Time frame: 1 year
Rate of in-hospital mortality based on SIRS criteria
Time frame: 1 year
Duration of hospital length of stay in days based on SIRS criteria
Time frame: 1 year
Rate of patient readmissions within 30 days
Dascena
Industry
Effect of a Sepsis Prediction Algorithm on Patient Mortality, Length of Stay, and Readmission
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04819035
Adult Disease, Disease
Indianapolis, Indiana, United States
View Trial DetailsNCT04804306
Adult Disease, Disease
Hackensack, New Jersey, United States
View Trial DetailsNCT04353388
Adult Disease, Disease
St Louis, Missouri, United States
View Trial DetailsNCT04291417
Adult Disease, Disease
Temple, Texas, United States
View Trial Details